This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,995.38 firm-fixed-price delivery order is for the supply of RESTASIS 0.05% eye emulsion, a specialty medication used to treat dry eye disease. This contract award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have any set-aside designation, indicating open competition. The contract will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, and the ultimate completion date is December 18, 2024.
Generated 3/18/25, 9:59 AM